AlphaMark Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-310
Closed -$11K 522
2018
Q4
$11K Sell
310
-25,506
-99% -$829K 0.01% 306
2018
Q3
$920K Sell
25,816
-1,275
-5% -$45K 0.37% 54
2018
Q2
$935K Sell
27,091
-7,755
-22% -$272K 0.38% 57
2018
Q1
$1.17M Buy
34,846
+9,865
+39% +$312K 0.5% 46
2017
Q4
$954K Sell
24,981
-1,189
-5% -$47.5K 0.37% 58
2017
Q3
$981K Buy
26,170
+2,850
+12% +$101K 0.42% 56
2017
Q2
$870K Hold
23,320
0.37% 65
2017
Q1
$915K Hold
23,320
0.43% 59
2016
Q4
$812K Hold
23,320
0.42% 57
2016
Q3
$916K Hold
23,320
0.46% 50
2016
Q2
$881K Hold
23,320
0.52% 50
2016
Q1
$896K Sell
23,320
-7,420
-24% -$276K 0.48% 48
2015
Q4
$1.48M Buy
30,740
+8,480
+38% +$393K 0.75% 40
2015
Q3
$878K Hold
22,260
0.49% 45
2015
Q2
$947K Sell
22,260
-412
-2% -$16.4K 0.53% 47
2015
Q1
$895K Buy
22,672
+2,991
+15% +$110K 0.5% 51
2014
Q4
$709K Sell
19,681
-7,019
-26% -$236K 0.44% 45
2014
Q3
$788K Hold
26,700
0.5% 40
2014
Q2
$671K Hold
26,700
0.4% 50
2014
Q1
$689K Buy
+26,700
New +$673K 0.42% 52

Other funds holding NTUS

AlphaMark Advisors's NTUS Position: Q1 2019 in Review

AlphaMark Advisors sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 310 shares — an estimated $11K sold.

AlphaMark Advisors first reported a position in NTUS in Q1 2014 and held it in 20 quarters. The position peaked at $1.48M in Q4 2015. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • AlphaMark Advisors reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • AlphaMark Advisors sold 310 Natus Medical Inc shares in Q1 2019, an estimated $11K.
  • AlphaMark Advisors first reported a position in Natus Medical Inc in Q1 2014 and held it in 20 quarters.
  • AlphaMark Advisors's Natus Medical Inc position peaked at $1.48M in Q4 2015.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on AlphaMark Advisors's 13F filing for Q1 2019, filed 9 May 2019.